# Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis

> **NCT03471988** · PHASE3 · COMPLETED · sponsor: **Asahi Kasei Therapeutics Corporation** · enrollment: 103 (actual)

## Conditions studied

- Deep Mycosis

## Interventions

- **DRUG:** AK1820
- **DRUG:** Voriconazole

## Key facts

- **NCT ID:** NCT03471988
- **Lead sponsor:** Asahi Kasei Therapeutics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-16
- **Primary completion:** 2021-04-21
- **Final completion:** 2021-04-21
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2021-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03471988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03471988, "Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT03471988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*